Clinical assessment of female sexual hormones and some antioxidant vitamins in Iraqi women with polycystic ovary syndrome according to body mass index and blood group variables
Year: 2024
Type: article
Study design: Observational Study
Abstract: Background. Polycystic ovary syndrome (PCOS) is defined as an endocrine disorder affecting women which causes infertility in their reproductive age presenting a variety of symptoms including acne, irregular menstruation, hirsutism obesity, hypertension and infertility. Aim of study. The present study was established for the assessment of Polycystic ovary syndrome (PCOS) patients sexual hormones and some vitamins. Materials and methods. Blood serum was clinically obtained from 180 Iraqi women (80 healthy women and 100 women diagnosed with PCOS). The subjects were selected depending on their blood groups (only positive) with approximately the same number of women in each group. Then they were separated into three groups according to their body mass index, ensuring that each group had a similar number of subjects to eliminate any randomness and errors in the results. Results and discussion. Luteinizing hormone (LH) and prolactin (PRL) were registered at a significantly high increase (p <0.0001), whereas follicle-stimulating hormone (FSH) showed a modest significant decrease (p <0.001) within females with PCOS when compared against the control group, while vitamins E, A, and C recorded a high significant decrease (p <0.0001) among PCOS women in contrast with the healthy group across all positive blood groups and body max indexes (BMIs) tested. Conclusion. Effect of the blood group and BMI on the values of the female sexual hormones (LH, FSH and PRL) and the vitamins (A, E and C). It was noticed that there was a high significant variation between the levels of LH and PRL in females infected with PCOS.
Authors: Ashwaq A. Shenta, Abbas D.M. Al-Maliki
Institutions: University of Basrah, Center for Clinical Studies
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $216
OpenAlex ID: W4403979552